Skip to content. Skip to main navigation.


Blog


Posts By "Douglas S. McNair, MD, PhD" clear


April 17, 2012

Big data is not (yet) big enough - part two


By: Douglas S. McNair, MD, PhD

The value of more diverse communities' using this data may be in the serendipitous opportunities that it creates. Not only will different communities look to new data sets with which to combine the primary data (research networks, and even social networks such as Facebook or Twitter), but they may also approach the problem from new angles.... Read full story


Category:

Comment(s): 0

Rating: 0/5

Tags:


March 28, 2012

Big data is not (yet) big enough - part one


By: Douglas S. McNair, MD, PhD

The promise of timely and reliable evidence in sufficient quantities to statistically ‘power' health care decisions depends on its quality, its interoperable ontological mapping of concepts (so that “apples” are really “apples”) and on the accessibility of the data on which to base discoveries and conclusions. These aspects are improving rapidly in health care Big Data recently, making that promise real. Detecting, identifying and doing analytical, descriptive-statistics procedures: there is no doubt that these must inform and define the best matches and optimal choices and improvement actions and predictive models.... Read full story


Category:

Comment(s): 0

Rating: 0/5

Tags:


December 19, 2011

The Sixth Estate in the cloud, intellectual property and the limits of collaboration


By: Douglas S. McNair, MD, PhD

There is a book (Justifying Intellectual Property) published last June by Robert Merges of Harvard and Cal-Berkeley law schools that you will want to read. It is exciting, beautifully written, and has strong relevance to discoveries and inventions that arise from observational research involving re-use of health data, including ‘panel' or population-level data such as are stored in multi-institution EHR-derived data warehouses and HIE repositories. In the book, Merges defends the importance of strong intellectual property protections in the present populist, pervasively-interconnected, social-network-obsessed information age that is so enthralled with unfettered collaboration for collaboration's sake.... Read full story


Category:

Comment(s): 0

Rating: 0/5

Tags:


October 20, 2011

Ethics and de-identified genomic plus phenotypic (health) data


By: Douglas S. McNair, MD, PhD

During the annual Cerner Health Conference last week, several clients came up to discuss my previous post and associated essay on de-identified health data. In my essay, I basically agree with Marc Lappé and others who have asserted that medical ethics as it exists and is practiced today is different from—and historically antagonistic toward—public health ethics (‘communitarian ethics'). This point of view is covered at some length in a paper by Eric Meslin and Ibrahim Garba in the September issue of Human Genetics.... Read full story


Category:

Comment(s): 0

Rating: 0/5

Tags:


September 13, 2011

De-Identified Health Data Have Characteristics of Quasi-Public Goods


By: Douglas S. McNair, MD, PhD

Cerner and many of our client institutions participate in de-identified databases that support observational and translational research. Such databases, called data warehouses, constitute a comprehensive source of de-identified, confidentiality-protected, real-world health data collected as a by-product of patient care. Cerner aggregates the data provided by participating facilities and uses stringent quality assurance processes to ensure the ongoing integrity of the information.... Read full story


Category:

Comment(s): 0

Rating: 0/5

Tags:


August 09, 2011

FDA Facing Huge Task in Regulating Mobile Medical Apps


By: Douglas S. McNair, MD, PhD

The FDA has already cleared a handful of mobile medical apps used by health care professionals, such as a smartphone-based ultrasound and an application for iPhones and iPads that allows doctors to view medical images and X-rays. But to-date, the FDA has not cleared any consumer-facing mobile medical apps. Nor does it appear that the FDA realizes how big a job this will be.... Read full story


Category:

Comment(s): 0

Rating: 0/5

Tags:

  1. 1